http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018147160-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3253ddc681af178948d48abfdbd1697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d63ceccb975761c4bc635312836bcfcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bac9f14b869d8b3c3f2ae7cb46d46ef2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
| filingDate | 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90491f0ff41d4f2b6d6a30beec428bcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6c0072d88f4467b4a0909403b73e46d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12be3fb0ffcfb94c88afbeb2e289555e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5915e9a457a4a61ce1cc3513daac53a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc96eb3ec3b7deea08ad9902d379e0ab |
| publicationDate | 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2018147160-A1 |
| titleOfInvention | Compositions for Use in Treating Parkinson's Disease and Related Disorders |
| abstract | The present invention relates to methods of treating and managing Parkinson's disease and related disorders. The methods especially find use in managing motor symptoms, including gait problems, particularly during advanced stages when effectiveness of standard medications wear off or side effects become problematic, as seen in Parkinson's disease, other disorders treated with dopaminergic agents, and other conditions associated with motor problems, such as aging or stroke. The treatment also may include disease-modifying effects, neuroprotection of, or neurorescue effects on neuronal cells in patients with Parkinson's disease and other neurodegenerative disorders. In particular, the invention relates to method of administering pharmaceutical compositions comprising effective amounts of tapentadol or a pharmaceutically acceptable salt or derivative thereof or, in other embodiments, stavudine or nabumetone, or a derivative thereof, for treating symptoms associated with Parkinson's disease, either as individual active agents, in combination with each other, or in combination with agents known to treat Parkinson's disease, such as the dopaminergic agent levodopa. The invention also relates to methods of preparing pharmaceutical compositions comprising effective amounts of tapentadol, stavudine, or nabumetone, or a derivative thereof, or further in combination with a dopaminergic agent, or derivative thereof, as well as to methods of using the pharmaceutical compositions in treating Parkinson's disease, related disorders, other conditions treated with dopaminergic agents, and other conditions with gait problems, for example by oral administration of the compositions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113473983-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020077235-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022256625-A1 |
| priorityDate | 2015-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.